Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study

Objective To study the effectiveness and safety of the non-vitamin K antagonist oral anticoagulants (novel oral anticoagulants, NOACs) dabigatran, rivaroxaban, and apixaban compared with warfarin in anticoagulant naïve patients with atrial fibrillation. Design Observational nationwide cohort study....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMJ
Hlavní autoři: Larsen, Torben Bjerregaard, Skjøth, Flemming, Nielsen, Peter Brønnum, Kjældgaard, Jette Nordstrøm, Lip, Gregory Y H
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group Ltd. 2016
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4910696/
https://ncbi.nlm.nih.gov/pubmed/27312796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.i3189
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky